Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06343896
Other study ID # AnkaraCHBilkent-tntaygurt
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date April 1, 2024
Est. completion date October 15, 2024

Study information

Verified date April 2024
Source Ankara City Hospital Bilkent
Contact TUGBA NUR TAYGURT, MD
Phone 05322005632
Email tugbanurtaygurt@gmail.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

In this study, we aimed to investigate the predictability of possible respiratory complications and the effect of the addition of the integrated pulmonary (EPI) score to the evaluation of the patient's respiratory index status in addition to the SPO2 measurement available in standard ASA monitoring in pediatric patients undergoing interventional radiological procedures under sedoanesthesia.


Description:

This study is a single-center observational study. Patients who will undergo interventional radiologic procedures under sedoanalgesia by the radiology clinic in the pediatric operating room of the hospital will be included in the study. This study is planned to include ASA 1-3 68 children aged 2-18 years. After obtaining the voluntary consent of the patients, anesthesia methods routinely applied in the hospital pediatric operating room will be applied. Noninvasive blood pressure, pulse oximetry, ECG, EPI and BS monitoring will be performed. Then 4 lt/min oxygen will be started with nasal EPI cannula. Pre-processing, 0.min, 1.min, 2.min, 4.min, 6.min, 8.min,10.dk and later systolic-diastolic and average arterial blood pressure, pulse, SPO2, BIS value, EPI value, number of breaths, ETCO2 will be recorded every 5 minutes. Apnea attacks will be recorded with ETCO2 tracking during the procedure. The capnographic criterion for an apnea episode is the inability to measure ETCO2 over a period of 15 seconds. Any apnea episode detected by clinical observation or any decrease of IPI ≤ 6 points, as well as a decrease of peripheral oxygen saturation to 92% and below, will be evaluated as hypoxia and result in an intervention including. 1. Stimulation of the patient 2. Discontinuation of the drug 3. Chin lift or chin push maneuver 4. Enhancing oxygen supplementation The necessary interventions will be performed in apnea and hypoxia states and the interventions applied when the hemodynamics of the patient is stable will be recorded The compilation time will be recorded by checking the eye opening, oral response and orientation improvement as cognitive parameters.


Recruitment information / eligibility

Status Recruiting
Enrollment 68
Est. completion date October 15, 2024
Est. primary completion date June 15, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 2 Years to 18 Years
Eligibility Inclusion Criteria: - ASA(American Society of Anesthesiologists classification) 1-2-3 ,2-18 years of age children patients who will be treated by interventional radiology Exclusion Criteria: - patients whose parents do not wish to participate in the research - patients with ASA scoring greater than 4 and 4' - Patients who are allergic to any of the drugs used or who have any contraindications for the use of the drug - Patients with advanced organ failure (heart, kidney, liver, lung) - Patients with intracranial mass (CIBAS), epilepsy or neuromuscular disease

Study Design


Related Conditions & MeSH terms


Intervention

Other:
monitorization reliability
evaluation of the use of the integral pulmonary index in the child patient group

Locations

Country Name City State
Turkey Ankara City Hospital, Bilkent Ankara

Sponsors (1)

Lead Sponsor Collaborator
Ankara City Hospital Bilkent

Country where clinical trial is conducted

Turkey, 

References & Publications (2)

Nelson O, Bailey PD Jr. Pediatric Anesthesia Considerations for Interventional Radiology. Anesthesiol Clin. 2017 Dec;35(4):701-714. doi: 10.1016/j.anclin.2017.08.003. — View Citation

Riphaus A, Wehrmann T, Kronshage T, Geist C, Pox CP, Heringlake S, Schmiegel W, Beitz A, Meining A, Muller M, von Delius S. Clinical value of the Integrated Pulmonary Index(R) during sedation for interventional upper GI-endoscopy: A randomized, prospectiv — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary EVALUATION OF IPI RELIABILITY IN PEDIATRIC PATIENTS RESPIRATORY STATUS OF THE PATIENT WILL BE MEASURED BY IPI MONITOR DURING INTERVENTIONAL RADIOLOGICAL PROCEDURES PERFORMED IN PEDIATRIC PATIENTS UNDER SEDOANALGESIA Just before induction, 1 min, 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min and then every 5 min until the patient comes out of anesthesia. maximum duration of anesthesia was determined as 60 minutes.
Secondary BIS correlation with the IPI The researchers aim to show the effect of BIS value differences on IPI score. Just before induction, 1 min, 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min and then every 5 min until the patient comes out of anesthesia. maximum duration of anesthesia was determined as 60 minutes.
Secondary pulse oximetry correlation with the IPI The researchers aim to show the effect of pulse oximetry value differences on IPI score. Just before induction, 1 min, 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min and then every 5 min until the patient comes out of anesthesia. maximum duration of anesthesia was determined as 60 minutes.
Secondary noninvasive blood pressure investigators will intermittently record the intraoperative patient's noninvasive blood pressure Just before induction, 1 min, 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min and then every 5 min until the patient comes out of anesthesia. maximum duration of anesthesia was determined as 60 minutes.
Secondary heart rate investigators will intermittently record the intraoperative patient's heart rate with ECG monitoring Just before induction, 1 min, 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min and then every 5 min until the patient comes out of anesthesia. maximum duration of anesthesia was determined as 60 minutes.
Secondary respiratory rate investigators will intermittently record the intraoperative patient's respiratory rate Just before induction, 1 min, 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min and then every 5 min until the patient comes out of anesthesia. maximum duration of anesthesia was determined as 60 minutes.
Secondary end tidal carbondioxide investigators will intermittently record the intraoperative patient's end tidal carbon dioxide value Just before induction, 1 min, 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min and then every 5 min until the patient comes out of anesthesia. maximum duration of anesthesia was determined as 60 minutes.
Secondary apnea and hypoxia conditions that develop in the patient during anesthesia The investigators will record the apnea and hypoxia that develop in the patient during anesthesia and whether they are intervened or not. hypoxia will be defined as a spo2 value of 92 and below. Just before induction, 1 min, 2 min, 4 min, 6 min, 8 min, 10 min, 15 min, 20 min, 25 min, 30 min and then every 5 min until the patient comes out of anesthesia. maximum duration of anesthesia was determined as 60 minutes.
Secondary postoperative recovery time From the end of the operation until the patient is recovered, the patient will be followed up in the recovery unit the first 30 minutes in the postoperative recovery unit will be evaluated
Secondary intraoperative total dose of medication used The investigators will record the total intraoperative drug dose at the end of the operation. at the end of the operation
Secondary postoperative nausea and vomiting will be evaluated in the recovery unit within the first 30 minutes in the perioperative period. the first 30 minutes in the postoperative recovery unit will be evaluated
See also
  Status Clinical Trial Phase
Recruiting NCT03399019 - Bispectral Index(BIS) on Depth of Sedation With Dexmedetomidine, Propofol and Midazolam During Spinal Anesthesia N/A
Completed NCT03220880 - Intranasal Dexmedetomidine Sedation in Children for Non-painful Procedures
Recruiting NCT04820205 - Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Procedural Sedation in Children N/A
Recruiting NCT04549623 - End-Tidal Carbon Dioxide Monitoring Device for Sedation During Endoscopic Ultrasonography N/A
Recruiting NCT04822064 - Comparison of Oral Chloral Hydrate and Combination of Intranasal Dexmedetomidine and Ketamine for Rescue After Failed Pediatric Procedural Sedation N/A
Completed NCT01527903 - A Comparison Between Propofol-Remifentanil and Midazolam-Remifentanil Sedation in the Intensive Care Unit Phase 4
Completed NCT01001533 - Assess the Ability of Electrical Cardiometry to Trend Hemodynamic Variables During Dexmedetomidine Sedation N/A
Completed NCT00747721 - Pharmacokinetics of Dexmedetomidine During Prolonged Infusion in ICU Phase 1
Completed NCT00158873 - Pharmaco-Economic Study Of Ultiva In Intensive Care Unit(ICU)Subjects Phase 4
Terminated NCT00205517 - Sedation and Psychopharmacology in Critical Care N/A
Recruiting NCT04096768 - The Use of Ketamine and Dexmedetomidine in Intensive Care Sedation Phase 3
Active, not recruiting NCT05082623 - The Effect of Music on Delirium, Pain, Need of Sedation, Anxiety and Vital Parameters N/A
Suspended NCT03285165 - Cerebral Vascular Effects of Dexmedetomidine Versus Propofol Sedation in Intubated Mechanically Ventilated ICU Patients Phase 2/Phase 3
Active, not recruiting NCT04788589 - Sedation and Ventilator Weaning Protocol in PICU N/A
Completed NCT03425474 - Study of Remimazolam Tosilate in Patients Undergoing Diagnostic Upper GI Endoscopy Phase 3
Recruiting NCT06061159 - The ED95 of Single Intravenous Bolus Remimazolam Besylate in Pediatric Patients During General Anesthesia Induction Phase 4
Completed NCT06449365 - Comparison of Intravenous V/S Nasal Atomizer Delivery of Midazolam for Conscious Sedation for No-scalpel Vasectomy Phase 4
Completed NCT02171910 - Doxapram as an Additive to Propofol Sedation in Sedation for ERCP Phase 4
Completed NCT02211118 - Sedation and Physiological Effects of Intranasal Dexmedetomidine in Severe COPD Phase 4
Completed NCT01694745 - EUROpean Pain Audit In Neonates N/A